The cytotoxic activity of the synthesized compounds was evaluated against two human cancer cell lines including A2780/RCIS, cisplatin resistant human ovarian carcinoma (MRP2-overexpressing ovarian carcinoma); A2780, drug-sensitive ovarian carcinoma. Here, ABCC2 is linked to ovarian carcinoma.